Publication | Open Access

Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults

ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseMetabolic DisorderLiver PhysiologyDiabetesPathologyAdvanced Glycation End-productsLiver DiseaseDecoy Soluble ReceptorFatty Liver DiseaseMetabolismMedicineSerum LevelsHealth Sciences